NCT06614218View on ClinicalTrials.gov

MIMS® Retrospective Chart Review

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Open Angle Glaucoma
Interventions
DEVICE

Minimally Invasive Micro Sclerostomy

The MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the eye.

Trial Locations (1)

Unknown

S. Malayan Eye Center, Yerevan

All Listed Sponsors
lead

Sanoculis Ltd

INDUSTRY

NCT06614218 - MIMS® Retrospective Chart Review | Biotech Hunter | Biotech Hunter